1. Pulmonary Diseases, a Matter of Time
   Cecilia G. Sanchez, 2017 CrossRef
2. Mitochondrial DNA content reduction induces aerobic glycolysis and reversible resistance to drug-induced apoptosis in SW480 colorectal cancer cells
   Jing-jing Mou et al, 2018, Biomedicine & Pharmacotherapy CrossRef
3. A family case with germline TSC1 and mtDNA mutations developing bilateral eosinophilic chromophobe renal cell carcinomas without other typical phenotype of tuberous sclerosis
   Hiromasa Sakamoto et al, 2018, J Clin Pathol CrossRef
4. Genome-wide screening identifies novel genes and biological processes implicated in cisplatin resistance
   Tengyu Ko et al, 2019, The FASEB Journal CrossRef
5. Advanced technological tools to study multidrug resistance in cancer
   Luca Andrei et al, 2019, Drug Resistance Updates CrossRef
6. Mitochondrial DNA alterations may influence the cisplatin responsiveness of oral squamous cell carcinoma
   Amnani Aminuddin et al, 2020, Sci Rep CrossRef
7. mtDNA mutations in cancer
   Giulia Girolimetti et al, 2020 CrossRef
8. Hierarchical nanoclusters with programmed disassembly for mitochondria-targeted tumor therapy with MR imaging
   Congkun Xie et al, 2021, Biomater. Sci. CrossRef
9. Potential role of heteroplasmic mitochondrial DNA mutations in modulating the subtype-specific adaptation of oral squamous cell carcinoma to cisplatin therapy
   Amnani Aminuddin et al, 2024, Discov Onc CrossRef
10. D-loop mutations in mitochondrial DNA are a risk factor for chemotherapy resistance in esophageal cancer
    Takashi Harino et al, 2024, Sci Rep CrossRef